Thursday, April 3, 2025

Radformation to Accelerate AI-Based Solutions with Limbus AI Acquisition

Related stories

Amazon simplifies access to Amazon Nova Gen AI models

Work with our foundation models on nova.amazon.com and access...

GE HealthCare & FPT Expand AI Healthcare Partnership

Global IT firm FPT and GE HealthCare announced a...

121G Launches HealthCoach, an AI Chronic Care Platform

121G Consulting proudly announces the release of its AI-based...

Covera Health Unveils ‘Protect Her™’ for Early Detection

New AI-powered platform leverages routine imaging to identify hidden...

Gayle deDie Named Cavallo’s SVP of Marketing

Cavallo, the leader in AI-powered Profit Maximization, announced Gayle...
spot_imgspot_img

Radformation, Inc., a leader in automation solutions for cancer care, announced that it has acquired privately-held Limbus AI, a leading global provider of automated contouring software for radiation therapy. This acquisition signifies Radformation’s commitment to driving innovation and expanding its AI-driven capabilities in cancer care.

“Our mission has always been to improve the radiation therapy process, focusing on efficiency, quality, and safety in patient care,” said Kurt Sysock, CEO of Radformation. “With Limbus’ innovative technology and expertise now part of our team, we are even more equipped to advance the frontier of innovative software solutions in radiation therapy.”

This merger aims to harness the collective strengths of both companies’ platforms by integrating the superior features of each system, offering the most advanced AI-driven contouring solution available today. Beyond improving contouring, this effort is expected to spark further innovation, leading to new developments and improvements in radiation therapy.

Also Read: Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.

“We share a similar vision to bring innovative software to patient care,” said Karl Otto, CEO of Limbus AI. “Both companies have very talented and hard working teams that, when combined, will be able to achieve great things together.”

Radformation’s acquisition of Limbus AI unites two leaders in clinical treatment planning, combining Radformation’s extensive global presence and robust product utilization – spanning 8 products used in over 1,600 clinics in 28 countries – with Limbus’ significant impact on 500,000 patients across 400 centers worldwide. This alliance will accelerate innovation, expand reach, and enhance patient outcomes worldwide, marking a new era in healthcare technology.

Source: BusinessWire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img